Guardian Pharmacy Services, Inc. Financials
This page shows Guardian Pharmacy Services, Inc. (GRDN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Guardian Pharmacy Services, Inc. has an operating margin of 5.0%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 33/100, indicating healthy but not exceptional operating efficiency. This is up from -5.1% the prior year.
Guardian Pharmacy Services, Inc.'s revenue surged 17.9% year-over-year to $1.4B, reflecting rapid business expansion. This strong growth earns a score of 63/100.
Guardian Pharmacy Services, Inc. carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Guardian Pharmacy Services, Inc.'s current ratio of 1.38 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 23/100, which could limit financial flexibility.
Guardian Pharmacy Services, Inc. has a free cash flow margin of 6.0%, earning a moderate score of 40/100. The company generates positive cash flow after capital investments, but with room for improvement.
Guardian Pharmacy Services, Inc.'s ROE of 22.6% shows moderate profitability relative to equity, earning a score of 61/100. This is up from -73.4% the prior year.
Guardian Pharmacy Services, Inc. scores 12.03, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.4B) relative to total liabilities ($194.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Guardian Pharmacy Services, Inc. passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Guardian Pharmacy Services, Inc. generates $2.04 in operating cash flow ($100.3M OCF vs $49.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Guardian Pharmacy Services, Inc. earns $109.3 in operating income for every $1 of interest expense ($72.7M vs $665K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Guardian Pharmacy Services, Inc. generated $1.4B in revenue in fiscal year 2025. This represents an increase of 17.9% from the prior year.
Guardian Pharmacy Services, Inc.'s EBITDA was $95.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 320.3% from the prior year.
Guardian Pharmacy Services, Inc. reported $49.2M in net income in fiscal year 2025. This represents an increase of 144.7% from the prior year.
Cash & Balance Sheet
Guardian Pharmacy Services, Inc. generated $86.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 100.8% from the prior year.
Guardian Pharmacy Services, Inc. held $65.6M in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
Guardian Pharmacy Services, Inc.'s gross margin was 20.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.
Guardian Pharmacy Services, Inc.'s operating margin was 5.0% in fiscal year 2025, reflecting core business profitability. This is up 10.1 percentage points from the prior year.
Guardian Pharmacy Services, Inc.'s net profit margin was 3.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 12.4 percentage points from the prior year.
Guardian Pharmacy Services, Inc.'s ROE was 22.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 96.0 percentage points from the prior year.
Capital Allocation
Guardian Pharmacy Services, Inc. invested $13.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 8.8% from the prior year.
GRDN Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $397.6M+5.3% | $377.4M+9.6% | $344.3M+4.6% | $329.3M-2.7% | $338.6M+7.7% | $314.4M+4.8% | $300.0M+8.9% | $275.4M |
| Cost of Revenue | $312.1M+3.1% | $302.7M+9.6% | $276.2M+4.2% | $265.0M-2.4% | $271.5M+7.1% | $253.5M+6.2% | $238.7M+8.4% | $220.3M |
| Gross Profit | $85.5M+14.4% | $74.7M+9.6% | $68.1M+5.9% | $64.3M-4.1% | $67.1M+10.2% | $60.9M-0.7% | $61.3M+11.2% | $55.1M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $54.7M-6.2% | $58.4M+5.0% | $55.6M+8.2% | $51.3M+2.0% | $50.3M-69.6% | $165.5M+273.7% | $44.3M-6.1% | $47.2M |
| Operating Income | $30.8M+88.1% | $16.4M+30.0% | $12.6M-3.3% | $13.0M-22.4% | $16.8M+116.0% | -$104.6M-715.2% | $17.0M+114.4% | $7.9M |
| Interest Expense | $163K+1.9% | $160K-7.0% | $172K+1.2% | $170K-59.6% | $421K-59.0% | $1.0M-3.8% | $1.1M+39.3% | $765K |
| Income Tax | $9.8M+39.7% | $7.0M+87.2% | $3.8M-1.9% | $3.8M-12.5% | $4.4M+2388.6% | $176K | $0 | $0 |
| Net Income | $20.9M+113.1% | $9.8M+8.7% | $9.0M-4.4% | $9.4M+94.9% | $4.8M+104.0% | -$122.0M | $0-100.0% | $7.1M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GRDN Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $412.7M+5.8% | $390.0M+9.5% | $356.3M+6.7% | $334.0M+4.1% | $320.8M-7.8% | $348.0M | N/A | N/A |
| Current Assets | $221.6M+11.8% | $198.3M+16.3% | $170.5M+2.7% | $166.0M+9.3% | $152.0M-15.7% | $180.3M | N/A | N/A |
| Cash & Equivalents | $65.6M+79.8% | $36.5M+93.9% | $18.8M+34.4% | $14.0M+200.4% | $4.7M-87.5% | $37.2M+2320.1% | $1.5M+783.9% | $174K |
| Inventory | $43.4M-9.4% | $47.9M+8.4% | $44.2M+1.7% | $43.4M+7.1% | $40.5M-10.3% | $45.2M | N/A | N/A |
| Accounts Receivable | $101.6M-4.3% | $106.2M+12.8% | $94.1M-3.4% | $97.4M+0.3% | $97.2M+6.8% | $90.9M | N/A | N/A |
| Goodwill | $79.7M+0.2% | $79.6M+4.5% | $76.2M+9.9% | $69.3M0.0% | $69.3M+1.3% | $68.4M | N/A | N/A |
| Total Liabilities | $194.7M+0.1% | $194.5M+10.1% | $176.7M+3.4% | $170.8M0.0% | $170.8M-20.2% | $214.1M | N/A | N/A |
| Current Liabilities | $160.7M-0.8% | $161.9M+12.5% | $144.0M-0.9% | $145.3M+0.8% | $144.1M-9.0% | $158.3M | N/A | N/A |
| Long-Term Debt | $0 | N/A | N/A | N/A | $0-100.0% | $28.7M | N/A | N/A |
| Total Equity | $217.9M+11.5% | $195.5M+8.8% | $179.7M+10.1% | $163.2M+8.8% | $150.0M+12.0% | $133.9M+134.0% | $57.2M+1.1% | $56.6M |
| Retained Earnings | $66.3M+46.1% | $45.4M+27.6% | $35.6M+34.0% | $26.6M+55.2% | $17.1M+230.5% | $5.2M | N/A | N/A |
GRDN Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $34.6M+22.8% | $28.2M+41.3% | $19.9M+13.6% | $17.6M-21.4% | $22.3M+1132.2% | -$2.2M-107.4% | $29.1M+236.6% | $8.7M |
| Capital Expenditures | $495K-87.6% | $4.0M | N/A | N/A | $2.3M+1.5% | $2.2M | N/A | N/A |
| Free Cash Flow | $34.1M+41.1% | $24.2M | N/A | N/A | $20.1M+558.5% | -$4.4M | N/A | N/A |
| Investing Cash Flow | -$4.7M+47.5% | -$9.0M+31.1% | -$13.0M-134.5% | -$5.5M+16.3% | -$6.6M+6.5% | -$7.1M+46.0% | -$13.1M-264.2% | -$3.6M |
| Financing Cash Flow | -$758K+50.6% | -$1.5M+27.5% | -$2.1M+20.7% | -$2.7M+94.5% | -$48.3M-207.4% | $44.9M+406.4% | -$14.7M-160.3% | -$5.6M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GRDN Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 21.5%+1.7pp | 19.8%+0.0pp | 19.8%+0.3pp | 19.5%-0.3pp | 19.8%+0.5pp | 19.4%-1.1pp | 20.4%+0.4pp | 20.0% |
| Operating Margin | 7.7%+3.4pp | 4.3%+0.7pp | 3.6%-0.3pp | 4.0%-1.0pp | 5.0%+38.2pp | -33.3%-38.9pp | 5.7%+2.8pp | 2.9% |
| Net Margin | 5.3%+2.7pp | 2.6%-0.0pp | 2.6%-0.2pp | 2.9%+1.4pp | 1.4%+40.2pp | -38.8%-38.8pp | 0.0%-2.6pp | 2.6% |
| Return on Equity | 9.6%+4.6pp | 5.0%0.0pp | 5.0%-0.8pp | 5.8%+2.6pp | 3.2%+94.3pp | -91.1%-91.1pp | 0.0%-12.5pp | 12.5% |
| Return on Assets | 5.1%+2.6pp | 2.5%0.0pp | 2.5%-0.3pp | 2.8%+1.3pp | 1.5%+36.6pp | -35.0% | N/A | N/A |
| Current Ratio | 1.38+0.2 | 1.22+0.0 | 1.18+0.0 | 1.14+0.1 | 1.05-0.1 | 1.14 | N/A | N/A |
| Debt-to-Equity | 0.00-1.0 | 1.00+0.0 | 0.98-0.1 | 1.05+1.0 | 0.00-0.2 | 0.21 | N/A | N/A |
| FCF Margin | 8.6%+2.2pp | 6.4% | N/A | N/A | 5.9%+7.3pp | -1.4% | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Guardian Pharmacy Services, Inc.'s annual revenue?
Guardian Pharmacy Services, Inc. (GRDN) reported $1.4B in total revenue for fiscal year 2025. This represents a 17.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Guardian Pharmacy Services, Inc.'s revenue growing?
Guardian Pharmacy Services, Inc. (GRDN) revenue grew by 17.9% year-over-year, from $1.2B to $1.4B in fiscal year 2025.
Is Guardian Pharmacy Services, Inc. profitable?
Yes, Guardian Pharmacy Services, Inc. (GRDN) reported a net income of $49.2M in fiscal year 2025, with a net profit margin of 3.4%.
What is Guardian Pharmacy Services, Inc.'s EBITDA?
Guardian Pharmacy Services, Inc. (GRDN) had EBITDA of $95.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Guardian Pharmacy Services, Inc. have?
As of fiscal year 2025, Guardian Pharmacy Services, Inc. (GRDN) had $65.6M in cash and equivalents against $0 in long-term debt.
What is Guardian Pharmacy Services, Inc.'s gross margin?
Guardian Pharmacy Services, Inc. (GRDN) had a gross margin of 20.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Guardian Pharmacy Services, Inc.'s operating margin?
Guardian Pharmacy Services, Inc. (GRDN) had an operating margin of 5.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Guardian Pharmacy Services, Inc.'s net profit margin?
Guardian Pharmacy Services, Inc. (GRDN) had a net profit margin of 3.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Guardian Pharmacy Services, Inc.'s return on equity (ROE)?
Guardian Pharmacy Services, Inc. (GRDN) has a return on equity of 22.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Guardian Pharmacy Services, Inc.'s free cash flow?
Guardian Pharmacy Services, Inc. (GRDN) generated $86.8M in free cash flow during fiscal year 2025. This represents a 100.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Guardian Pharmacy Services, Inc.'s operating cash flow?
Guardian Pharmacy Services, Inc. (GRDN) generated $100.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Guardian Pharmacy Services, Inc.'s total assets?
Guardian Pharmacy Services, Inc. (GRDN) had $412.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Guardian Pharmacy Services, Inc.'s capital expenditures?
Guardian Pharmacy Services, Inc. (GRDN) invested $13.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Guardian Pharmacy Services, Inc.'s current ratio?
Guardian Pharmacy Services, Inc. (GRDN) had a current ratio of 1.38 as of fiscal year 2025, which is considered adequate.
What is Guardian Pharmacy Services, Inc.'s debt-to-equity ratio?
Guardian Pharmacy Services, Inc. (GRDN) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Guardian Pharmacy Services, Inc.'s return on assets (ROA)?
Guardian Pharmacy Services, Inc. (GRDN) had a return on assets of 11.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Guardian Pharmacy Services, Inc.'s Altman Z-Score?
Guardian Pharmacy Services, Inc. (GRDN) has an Altman Z-Score of 12.03, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Guardian Pharmacy Services, Inc.'s Piotroski F-Score?
Guardian Pharmacy Services, Inc. (GRDN) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Guardian Pharmacy Services, Inc.'s earnings high quality?
Guardian Pharmacy Services, Inc. (GRDN) has an earnings quality ratio of 2.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Guardian Pharmacy Services, Inc. cover its interest payments?
Guardian Pharmacy Services, Inc. (GRDN) has an interest coverage ratio of 109.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Guardian Pharmacy Services, Inc.?
Guardian Pharmacy Services, Inc. (GRDN) scores 53 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.